Target intelligence / Profile preview

Integrin Alpha V Subunit (ITGAV)

Target
ITGAV
Molecular classification
Integrin alpha chain family, Receptor
01

Overview

Integrin alpha V, encoded by the ITGAV gene in humans, is a subunit of integrins—heterodimeric integral membrane proteins composed of an alpha and a beta subunit. These proteins are essential for cell surface adhesion to the extracellular matrix (ECM) and play key roles in signal transduction. Alpha V can pair with several beta chains (Beta 1, Beta 3, Beta 5, Beta 6, Beta 8), forming distinct integrin receptors with unique ligand specificities. It mediates cell adhesion to ECM components and signal transduction influencing cell proliferation, survival, and migration. Dysregulation is associated with diseases including viral infection susceptibility and cancer.

Other names
Integrin alpha-VVitronectin receptor alpha subunitCD51VNRA
02

Mechanism of action

Alpha V-containing integrins mediate cell adhesion to ECM components and signal transduction influencing cell proliferation, survival, and migration.

03

Biological functions

Cell adhesionSignal transductionCell proliferationCell survivalCell migrationAngiogenesisWound healingEmbryo implantation
04

Disease associations

CancerWest Nile Virus infection susceptibilityHerpes Simplex virus infection susceptibilityPathological angiogenesis
05

Safety considerations

Potential for off-target effects due to broad expression and multiple dimerization partners.

Beyond the preview

Go deeper on Integrin Alpha V Subunit (ITGAV).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrin Alpha V Subunit (ITGAV).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call